LivaNova (LIVN) Depreciation and Depletion (2015 - 2026)
LivaNova (LIVN) reported Depreciation and Depletion of $8.3 million for Q1 2026, up 29.3% on a YoY basis from $6.4 million in Q1 2025, and up 9.86% sequentially from $7.6 million in Q4 2025.
LivaNova (LIVN) Depreciation and Depletion (2015 - 2026) Analysis & Trends
LivaNova (LIVN) has 12 years of Depreciation and Depletion data on file, last reported at $8.3 million in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion rose 29.3% year-over-year to $8.3 million; the trailing twelve-month figure through Mar 2026 stood at $30.4 million (up 20.54% YoY), and the FY2025 full-year result was $28.6 million, up 13.78% from the prior year.
- Depreciation and Depletion grew to $8.3 million in Q1 2026, from $7.6 million in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $8.3 million in Q1 2026 to a low of $5.5 million in Q2 2022.
- A 5-year average of $6.4 million and a median of $6.2 million in 2024 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion dropped 11.86% in 2022 and climbed 29.3% in 2026, its largest moves.
- Tracing LIVN's Depreciation and Depletion over 5 years: stood at $5.8 million in 2022, then gained by 6.49% to $6.2 million in 2023, then increased by 4.32% to $6.4 million in 2024, then rose by 17.66% to $7.6 million in 2025, then increased by 9.86% to $8.3 million in 2026.
- Business Quant data shows LIVN's Depreciation and Depletion at $8.3 million in Q1 2026, $7.6 million in Q4 2025, and $7.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 308.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 89.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 78.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | LivaNova | 4.40 Bn | 3.86 Bn | 243.75 Mn | 8.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.30 Mn |
| Mar 31, 2026 | 8.30 Mn |
| Dec 31, 2025 | 7.56 Mn |
| Dec 31, 2025 | 7.56 Mn |
| Sep 30, 2025 | 7.72 Mn |
| Sep 30, 2025 | 7.72 Mn |
| Jun 30, 2025 | 6.87 Mn |
| Jun 30, 2025 | 6.87 Mn |
| Mar 31, 2025 | 6.42 Mn |
| Mar 31, 2025 | 6.42 Mn |
| Dec 31, 2024 | 6.42 Mn |
| Dec 31, 2024 | 6.42 Mn |
| Sep 30, 2024 | 6.24 Mn |
| Sep 30, 2024 | 6.24 Mn |
| Jun 30, 2024 | 6.18 Mn |
| Jun 30, 2024 | 6.18 Mn |
| Mar 31, 2024 | 6.27 Mn |
| Mar 31, 2024 | 6.27 Mn |
| Dec 31, 2023 | 6.16 Mn |
| Dec 31, 2023 | 6.16 Mn |